Next Article in Journal
Ferocious Beast
Previous Article in Journal
Secondary Polycythemia in a Sarcoma Patient: A Commentary about Cediranib
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 26
Issue 1
10.3747/co.26.4593
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Prevalence of Human T Cell Lymphotropic Virus 1 Infection in Canada

by
L. Amar
1,
M. Le
1,
F. M. Ghazawi
2,
E. Rahme
1,
A. Segal
1,
E. Netchiporouk
1,
G. Popradi
1,
L. Moreau
1,
O. Roshdy
1,
D. Sasseville
1 and
Ivan V. Litvinov
1,*
1
Division of Dermatology, McGill University, Montreal, QC H4A 3J1, Canada
2
Division of Dermatology, University of Ottawa, Ottawa, ON, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2019, 26(1), 3-5; https://doi.org/10.3747/co.26.4593
Submission received: 3 November 2018 / Revised: 8 December 2018 / Accepted: 12 January 2019 / Published: 1 February 2019

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Human T cell lymphotropic virus 1 (htlv-1) is a bloodborne retrovirus that infects at least 5–20 million people around the world [...]

Share and Cite

MDPI and ACS Style

Amar, L.; Le, M.; Ghazawi, F.M.; Rahme, E.; Segal, A.; Netchiporouk, E.; Popradi, G.; Moreau, L.; Roshdy, O.; Sasseville, D.; et al. Prevalence of Human T Cell Lymphotropic Virus 1 Infection in Canada. Curr. Oncol. 2019, 26, 3-5. https://doi.org/10.3747/co.26.4593

AMA Style

Amar L, Le M, Ghazawi FM, Rahme E, Segal A, Netchiporouk E, Popradi G, Moreau L, Roshdy O, Sasseville D, et al. Prevalence of Human T Cell Lymphotropic Virus 1 Infection in Canada. Current Oncology. 2019; 26(1):3-5. https://doi.org/10.3747/co.26.4593

Chicago/Turabian Style

Amar, L., M. Le, F. M. Ghazawi, E. Rahme, A. Segal, E. Netchiporouk, G. Popradi, L. Moreau, O. Roshdy, D. Sasseville, and et al. 2019. "Prevalence of Human T Cell Lymphotropic Virus 1 Infection in Canada" Current Oncology 26, no. 1: 3-5. https://doi.org/10.3747/co.26.4593

APA Style

Amar, L., Le, M., Ghazawi, F. M., Rahme, E., Segal, A., Netchiporouk, E., Popradi, G., Moreau, L., Roshdy, O., Sasseville, D., & Litvinov, I. V. (2019). Prevalence of Human T Cell Lymphotropic Virus 1 Infection in Canada. Current Oncology, 26(1), 3-5. https://doi.org/10.3747/co.26.4593

Article Metrics

Back to TopTop